|
|
 |
|
Viewing report
|
|
|
|
Medicated Skin Care in New Zealand
Euromonitor International, March 2012, Pages: 36
During 2010, Regulatory Reform Minister, Rodney Hide, introduced the Regulatory Responsibility Bill to review and remove hundreds of regulations that are considered to hinder business practice in New Zealand. With regard to medicated skin care, this review was intended to reduce compliance costs for manufacturers and importers of ‘related products’ among other things. Related products are defined in Section 94 of the Medicines Regulations Act 1984 as ‘a product that is primarily a food,...
The Medicated Skin Care in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Medicated Skin Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
|
|
|
|
